Advertisement

ASH 2019 MPN Updates- Novel Therapies for Myelofibrosis

ASH 2019 MPN Updates- Novel Therapies for Myelofibrosis Catriona Jamieson, MD, PhD, UC San Diego Moores Cancer Center, provides a brief summary of ASH novel therapies for MPN patients. For more information on ASH studies go to our MPN Clinical Trial page,

Ruxolitinib,Navitoclax,Fedratinib,

Post a Comment

0 Comments